EVENTS
Where can you meet us?
Meet us at upcoming industry events to learn how our synthetic DNA solutions can accelerate your research and therapeutic development. Our team will be on hand to discuss your needs. Book a meeting or drop by our booth to connect
The Switch to Cell-Free DNA: Strategic and Regulatory Considerations for Advanced Therapies
Original broadcast: 11 DEC 2025
On-demand webinar
WATCH NOW ON DEMAND
This webinar features Amy Walker, Ph.D., CEO, joined by guest speaker Jenny Mellquist, Ph.D., for a focused discussion on the strategic, technical, and regulatory steps required to transition from plasmid DNA to synthetic, cell-free DNA for advanced therapies.
Session Focus
A practical overview of the strategic and regulatory considerations involved in updating your critical starting material to next-generation, cell-free DNA.
Key Topics
Critical regulatory and CMC requirements for material substitution
Practical considerations for implementing the change within a cGMP environment
Technical and logistical advantages of cell-free DNA over pDNA
If you're planning 2026 programs and want to explore how synthetic, cell-free DNA can accelerate timelines and improve product purity, click here to watch the webinar.
Sequence to Solution: Synthetic DNA Accelerating Advanced Therapies
Original broadcast: 31 MARCH 2026
On-demand webinar
WATCH NOW ON DEMAND
Discover how synthetic DNA is transforming advanced therapies, enabling faster development of personalized cancer vaccines and mRNA treatments from sequence to clinic.
Bringing together two pioneering companies, Neomatrix Biotech and HelixNano, this webinar features insights from Luigi Aurisicchio, CEO, and Marianna Keaveney, CSO, as they share how synthetic DNA is powering their development pipelines and accelerating therapeutic innovation.
Key topics:
Accelerating development of personalised cancer vaccines and mRNA therapies
The role of DNA quality, accuracy, and customisation in clinical success
Real-world examples of overcoming development bottlenecks
Benefits of flexible, fast, scalable construct design
To see how synthetic DNA is accelerating therapeutic innovation, click here to watch the webinar.
mRNA-Based Therapeutics Summit
21-22 JULY 2026
Boston, MA
Join us at the mRNA Based Therapeutics Summit, where James Vang, VP BD and Curtis Alexander, BD Director will be there to discuss how our synthetic DNA solutions can support the development and manufacture of next-generation mRNA therapeutics.
We look forward to connecting with industry leaders and partners driving innovation across the mRNA landscape.
If you are attending, we’d love to connect. Schedule a meeting with our team to explore how 4basebio can support your next-generation therapies:
To book a meeting with James, click here.
To book a meeting with Curtis, click here.
Meet us at MSS 2026 Conference, where Styliani Kounadi, Scientist is excited to connect and share our latest advancements in synthetic DNA.
MSS2026 focuses on production solutions and advanced analytics across the development and manufacturing of gene therapies, vaccines and complex biological products.
We look forward to connecting with you there.
MSS 2026
14-17 SEPTEMBER 2026
Bled, Slovenia
CPI RNA Vaccines & Therapeutics Conference
15-16 SEPTEMBER 2026
London, UK
Join us at the CPI RNA Vaccines & Therapeutics Conference, where we will be showcasing our latest advancements in synthetic DNA for next-generation therapies and vaccines.
Hear first-hand from members of our Analytics team, Jaya Selvaraj, Analytics Scientist and Sangamesh, Analytics Development Scientist who will be presenting posters. Further details to be announced soon.
We look forward to connecting with researchers, partners and industry leaders across the RNA community.
If you're attending, we'd love to meet you.